Header Logo

Connection

LUKASZ SZARPAK to Dobutamine

Back to Details
This is a "connection" page, showing publications LUKASZ SZARPAK has written about Dobutamine.
LUKASZ SZARPAK
Connection Strength
0.576
Dobutamine
  1. Milrinone or dobutamine in patients with heart failure: evidence from meta-analysis. ESC Heart Fail. 2022 06; 9(3):2049-2050.
    View in: PubMed
    Score: 0.201
  2. Efficacy and safety of levosimendan and dobutamine in heart failure: A systematic review and meta-analysis. Cardiol J. 2021; 28(3):492-493.
    View in: PubMed
    Score: 0.188
  3. Levosimendan or dobutamine in patients with low cardiac output syndrome: Results from meta-analysis. Int J Cardiol. 2021 06 15; 333:145.
    View in: PubMed
    Score: 0.186
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.